Developer docs
API playgroundTry for free, no card

Search company profiles

Abwiz Bio

Full company profile

uuid0005eb3

Namestring
Abwiz Bio
Legal namestring
Abwiz Bio Inc.
Websiteurl
abwizbio.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Abwiz Bio is a privately held San Diego-based biotechnology company founded in September 2012 that provides custom monoclonal antibody discovery and engineering services to biopharmaceutical, in vitro diagnostics, pharmaceutical, and academic research customers. The company differentiates through a proprietary rabbit-phage display platform built on three core technologies: the patented WizAmp™ single-primer library construction method (US 9,890,414), a proprietary Fab-phagemid vector that enables expression of the full rabbit immune repertoire including Ckappa1 clones, and the STEM™ multi-stage affinity maturation platform that has demonstrated 1,300x affinity improvements and 4 pM KD outcomes.

The business operates a hybrid revenue model combining fee-for-service custom antibody development (rabbit mAb discovery, antibody humanization, and affinity maturation sold under royalty-free terms) with a direct-to-customer catalog of more than 440 pre-made research reagents — including 340 phospho-specific antibodies, cell surface antibodies (GPCRs, ion channels), and SARS-CoV-2 antibodies and proteins priced individually on the company's e-commerce site. Custom services are quote-based and sold through a consultative B2B motion anchored by a 'Talk to a Scientist' engagement channel, while catalog products ship globally through both direct e-commerce and a distributor network.

The company is founder-led, with CJ Okumura (PhD, MBA) as CEO and Toshi Maruyama (MD, PhD) as CSO/COO, supported by a team of approximately six scientists. Abwiz Bio has remained small and self-funded — its only disclosed external capital is a $225,000 raise in 2016 — while expanding its platform and product line steadily over more than a decade of operation.

Short descriptiontext

Abwiz Bio is a San Diego-based biotech providing custom rabbit monoclonal antibody discovery, humanization, and affinity maturation services to biopharma, IVD, and academic customers using a proprietary phage display platform, alongside a catalog of 440+ research reagent antibodies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
monoclonal antibody services, phage display technology, custom antibody development, antibody humanization, affinity maturation
Industry4 codes
PRIMARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAAAAF
Bispecific & Multispecific Antibodies
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYHLAAAAAA
Monoclonal Antibody Therapeutics (mAbs)
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Pharmaceutical Preparations2834
Product category
Custom Antibody Development Services
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Custom Antibody Development Services
TypeProfessional Services
Description

Fee-for-service custom antibody development including rabbit monoclonal antibody discovery, antibody humanization, and affinity maturation services. Customers pay upfront for research services with royalty-free terms on resulting antibodies.

abwizbio.com
2Catalog Antibody Products
TypeOne Time License
Description

Sale of pre-made monoclonal antibodies from product catalog including phospho antibodies, cell surface antibodies, SARS-CoV-2 antibodies, and other research reagents. Products sold in various formats (unconjugated, biotin, FITC, PE, APC conjugates).

abwizbio.com
3Licensing and OEM
TypeLicensing Royalties
Description

Company licenses products and technologies to customers, and supplies OEM products as part of business model.

abwizbio.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details2 tiers
1Catalog antibodies with various conjugate formats
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Prices vary by product and conjugate format. Examples: Anti-PLXDC2 unconjugated from $99.00, Biotin conjugate $175.00, CTX-M antibody $210.00, Cleaved PARP APC conjugate $118.80. Sizes include 20uL, 200uL, 100 Tests, and 10 Tests formats.

abwizbio.com
2Custom service contracts
ModelOtherBilling cadenceMulti-year contract
Notes

Fee-for-service pricing is quote-based and not publicly disclosed. Royalty-free terms available for custom antibody development.

abwizbio.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1RabWiz™
Description

Proprietary platform for custom rabbit monoclonal antibody production combining rabbit immune response with phage display technology.

abwizbio.com
+2 more records
Core offering1 text field

Abwiz Bio provides end-to-end custom monoclonal antibody development services using proprietary phage display technology combined with rabbit immunization. The company delivers high-affinity, high-specificity rabbit monoclonal antibodies for difficult targets including GPCRs, ion channels, and small molecules, along with antibody humanization, affinity maturation, and cell-based panning services. They also sell a catalog of 440+ research antibodies and license their proprietary platforms and products to customers globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 1,300× affinity improvement achieved (example: 5 nM KD starting affinity improved to 4 pM KD)
+5 more records
Product overview1 text field

Abwiz Bio is a biotech company offering end-to-end custom monoclonal antibody development services built on proprietary phage display technology. The core platform consists of Rabwiz™ for rabbit monoclonal antibody discovery, STEM™ for antibody affinity maturation and optimization, and WizAmp™ (US 9,890,414) for patented library construction. The company also maintains a catalog of over 440 products including phospho-specific antibodies (340 items), SARS-CoV-2 antibodies and proteins, cell surface antibodies (GPCRs, ion channels), and other research antibodies. Services span antibody discovery, humanization, and lead optimization for research, diagnostic, and therapeutic applications.

Product and service10 records
1Rabwiz™ Custom Rabbit Monoclonal Antibody Development
CategoryCustom Antibody Development Service
Description

Fee-for-service custom rabbit monoclonal antibody discovery and development service that combines the high precision of rabbit immune response with phage display selection. Delivers high-affinity, high-specificity antibodies for difficult targets including GPCRs, ion channels, and small molecules, for biotech, pharma, and diagnostics customers.

2STEM™ Antibody Affinity Maturation Service
CategoryAntibody Engineering Service
Description

Multi-stage antibody affinity maturation service combining computational CDR design with comprehensive benchtop phage display selection. Engineers enhanced antibody function including improved affinity, pH sensitivity, expression, and developability, with demonstrated 1,300× affinity improvements and 4 pM KD outcomes.

3Antibody Humanization and Optimization Service
CategoryAntibody Engineering Service
Description

CDR grafting and framework optimization service that transforms non-human antibodies (mouse, rabbit, llama, alpaca) into humanized therapeutic candidates with reduced immunogenicity. 15/15 (100%) humanization success rate across programs.

4Cell-based Phage Display Panning (Native Antigen Panning)
CategoryCustom Antibody Development Service
Description

Cell-based phage display selection service using native antigen formats to obtain functional antibodies that recognize native cell-surface proteins. Combines peptide, recombinant protein, and cell-based antigen formats during panning to obtain clones with native functionality.

5SARS-CoV-2 Antibody Catalog
CategoryCatalog Research Antibodies
Description

Catalog of rabbit monoclonal antibodies and humanized neutralizing antibodies targeting SARS-CoV-2 proteins including nucleoprotein and spike protein variants, sold in multiple conjugate formats and sizes for research use.

6SARS-CoV-2 Protein Catalog
CategoryCatalog Research Reagents
Description

Catalog of recombinant SARS-CoV-2 proteins including spike trimers from wild-type and variant strains (Omicron, Delta, Alpha, Beta) with various tags for research applications.

7Phospho-Specific Antibody Catalog
CategoryCatalog Research Antibodies
Description

Catalog of phospho-specific rabbit monoclonal antibodies for detection of phosphorylated proteins in applications including flow cytometry, Western blot, ELISA, and IHC, sold in unconjugated and conjugate formats.

8Cell Surface Antibody Catalog
CategoryCatalog Research Antibodies
Description

Catalog of antibodies targeting cell surface antigens including GPCRs such as CB1 and CB2, ion channels such as Kv1.3, and other membrane proteins for flow cytometry applications, sold in multiple conjugate formats.

9Other Research Antibodies Catalog
CategoryCatalog Research Antibodies
Description

Miscellaneous research antibodies including cleaved PARP, CTX-M, NOD1, p53, and isotype control antibodies for general research use.

10Platform and Product Licensing / OEM
CategoryTechnology Licensing
Description

Licensing of proprietary platforms (including Rabwiz, STEM, and WizAmp) and OEM supply of Abwiz products to other companies for resale or integration into their product lines.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Academic Research Institutions
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Abwiz Bio welcomes collaboration with academic researchers for novel therapeutic mAb development or immunology studies. Company can jointly apply for NIH SBIR and STTR grants with academic partners. Open to developing antibodies in collaboration after evaluating target potential.

abwizbio.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Abwiz Bio services available through ScienceExchange platform, which provides verified vendor access for research services. Platform enables academic and commercial customers to order Abwiz services through established procurement channels.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AbCellera is a leading antibody discovery CRO that uses proprietary single-cell and display technologies to deliver therapeutic antibody leads to pharma partners. It directly competes with Abwiz in custom antibody discovery for biopharma customers, though at much greater scale and capital base.

TypeDirect peer
Description

Adimab operates a yeast-based antibody discovery platform serving pharma and biotech with fully human leads. It is a direct competitor in the antibody discovery CRO market, offering an alternative display technology approach to Abwiz's rabbit/phage-display platform.

TypeDirect peer
Description

GenScript's ProBio division offers end-to-end antibody discovery, engineering, and manufacturing services including phage display and humanization. It overlaps directly with Abwiz's Rabwiz discovery, humanization, and affinity maturation services, but at significantly larger scale and global reach.

TypeDirect peer
Description

Creative Biolabs is a CRO offering custom antibody services across hybridoma, phage display, and humanization workflows for therapeutic and diagnostic clients. It is a direct peer in the custom rabbit and humanized antibody development space with a similar fee-for-service model.

TypeBroad incumbent
Description

Cell Signaling Technology is a leading producer of validated antibodies and reagents for signal transduction and disease research. Its broad catalog of highly validated antibodies overlaps with Abwiz's phospho-specific and cell-surface product lines, though CST focuses on rabbit monoclonal reagents rather than custom discovery services.

TypeBroad incumbent
Description

BioLegend, now part of Revvity/PerkinElmer, is one of the largest catalog antibody reagent suppliers and was the prior employer of Abwiz CEO CJ Okumura. Its catalog overlaps with Abwiz's reagent business, but BioLegend is far broader and does not focus on custom rabbit mAb discovery.

7Absolute Antibody
TypeDirect peer
Description

Absolute Antibody offers antibody engineering, humanization, and recombinant antibody services, including reformatted rabbit monoclonals. It overlaps with Abwiz's humanization service and recombinant IgG production, and competes for therapeutic developers seeking royalty-free antibody ownership.

TypeDirect peer
Description

ProMab is a custom monoclonal antibody development CRO offering hybridoma, phage display, and humanization services to academic and biotech customers. It is a direct peer for custom rabbit and humanized mAb services, particularly for research-scale and preclinical projects.

TypeEmerging player
Description

Synaptic Systems produces high-quality rabbit monoclonal antibodies for neuroscience and cell biology research. While more focused on a single research vertical, it competes with Abwiz's catalog rabbit mAb offerings for share of academic and biotech reagent budgets.

10Distributed Bio (Charles River Laboratories)
TypeBroad incumbent
Description

Distributed Bio, now part of Charles River Laboratories, offers antibody discovery and optimization using computational and library-based methods. Its Therapeutic Antibody Discovery and AbClonal services overlap with Abwiz's Rabwiz and STEM platforms within a much larger discovery services portfolio.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Abwiz Bio

Custom Antibody Development Servicesabwizbio.com

Abwiz Bio is a San Diego-based biotech providing custom rabbit monoclonal antibody discovery, humanization, and affinity maturation services to biopharma, IVD, and academic customers using a proprietary phage display platform, alongside a catalog of 440+ research reagent antibodies.

What Abwiz Bio does

Abwiz Bio is a privately held San Diego-based biotechnology company founded in September 2012 that provides custom monoclonal antibody discovery and engineering services to biopharmaceutical, in vitro diagnostics, pharmaceutical, and academic research customers. The company differentiates through a proprietary rabbit-phage display platform built on three core technologies: the patented WizAmp™ single-primer library construction method (US 9,890,414), a proprietary Fab-phagemid vector that enables expression of the full rabbit immune repertoire including Ckappa1 clones, and the STEM™ multi-stage affinity maturation platform that has demonstrated 1,300x affinity improvements and 4 pM KD outcomes.

The business operates a hybrid revenue model combining fee-for-service custom antibody development (rabbit mAb discovery, antibody humanization, and affinity maturation sold under royalty-free terms) with a direct-to-customer catalog of more than 440 pre-made research reagents — including 340 phospho-specific antibodies, cell surface antibodies (GPCRs, ion channels), and SARS-CoV-2 antibodies and proteins priced individually on the company's e-commerce site. Custom services are quote-based and sold through a consultative B2B motion anchored by a 'Talk to a Scientist' engagement channel, while catalog products ship globally through both direct e-commerce and a distributor network.

The company is founder-led, with CJ Okumura (PhD, MBA) as CEO and Toshi Maruyama (MD, PhD) as CSO/COO, supported by a team of approximately six scientists. Abwiz Bio has remained small and self-funded — its only disclosed external capital is a $225,000 raise in 2016 — while expanding its platform and product line steadily over more than a decade of operation.

Abwiz Bio firmographics

Firmographics
Name
Abwiz Bio
Legal name
Abwiz Bio Inc.
Website
https://abwizbio.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
1–10 employees
Short description
Abwiz Bio is a San Diego-based biotech providing custom rabbit monoclonal antibody discovery, humanization, and affinity maturation services to biopharma, IVD, and academic customers using a proprietary phage display platform, alongside a catalog of 440+ research reagent antibodies.
Ownership category
akta.pro rank

Abwiz Bio industry classification

Industry
Product category
Custom Antibody Development Services
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)
SIC
Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAAAAF
Bispecific & Multispecific Antibodies
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYHLAAAAAA
Monoclonal Antibody Therapeutics (mAbs)
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)

Keywords

  • Monoclonal antibody services
  • Phage display technology
  • Custom antibody development
  • Antibody humanization
  • Affinity maturation

Where Abwiz Bio is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Abwiz Bio business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Custom Antibody Development Services: Fee-for-service custom antibody development including rabbit monoclonal antibody discovery, antibody humanization, and affinity maturation services. Customers pay upfront for research services with royalty-free terms on resulting antibodies.
  2. Catalog Antibody Products: Sale of pre-made monoclonal antibodies from product catalog including phospho antibodies, cell surface antibodies, SARS-CoV-2 antibodies, and other research reagents. Products sold in various formats (unconjugated, biotin, FITC, PE, APC conjugates).
  3. Licensing and OEM: Company licenses products and technologies to customers, and supplies OEM products as part of business model.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCatalog antibodies with various conjugate formats
OtherMulti-year contractCustom service contracts

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Abwiz Bio product offering

Product offering

Core offering

Abwiz Bio provides end-to-end custom monoclonal antibody development services using proprietary phage display technology combined with rabbit immunization. The company delivers high-affinity, high-specificity rabbit monoclonal antibodies for difficult targets including GPCRs, ion channels, and small molecules, along with antibody humanization, affinity maturation, and cell-based panning services. They also sell a catalog of 440+ research antibodies and license their proprietary platforms and products to customers globally.

Product overview

Abwiz Bio is a biotech company offering end-to-end custom monoclonal antibody development services built on proprietary phage display technology. The core platform consists of Rabwiz™ for rabbit monoclonal antibody discovery, STEM™ for antibody affinity maturation and optimization, and WizAmp™ (US 9,890,414) for patented library construction. The company also maintains a catalog of over 440 products including phospho-specific antibodies (340 items), SARS-CoV-2 antibodies and proteins, cell surface antibodies (GPCRs, ion channels), and other research antibodies. Services span antibody discovery, humanization, and lead optimization for research, diagnostic, and therapeutic applications.

Differentiator

Problem solved

Functional benefit

Brands

  • RabWiz™: Proprietary platform for custom rabbit monoclonal antibody production combining rabbit immune response with phage display technology.
  • STEM™
  • WizAmp™

Products and services

  • Rabwiz™ Custom Rabbit Monoclonal Antibody Development Fee-for-service custom rabbit monoclonal antibody discovery and development service that combines the high precision of rabbit immune response with phage display selection. Delivers high-affinity, high-specificity antibodies for difficult targets including GPCRs, ion channels, and small molecules, for biotech, pharma, and diagnostics customers.
  • STEM™ Antibody Affinity Maturation Service Multi-stage antibody affinity maturation service combining computational CDR design with comprehensive benchtop phage display selection. Engineers enhanced antibody function including improved affinity, pH sensitivity, expression, and developability, with demonstrated 1,300× affinity improvements and 4 pM KD outcomes.
  • Antibody Humanization and Optimization Service CDR grafting and framework optimization service that transforms non-human antibodies (mouse, rabbit, llama, alpaca) into humanized therapeutic candidates with reduced immunogenicity. 15/15 (100%) humanization success rate across programs.
  • Cell-based Phage Display Panning (Native Antigen Panning) Cell-based phage display selection service using native antigen formats to obtain functional antibodies that recognize native cell-surface proteins. Combines peptide, recombinant protein, and cell-based antigen formats during panning to obtain clones with native functionality.
  • SARS-CoV-2 Antibody Catalog Catalog of rabbit monoclonal antibodies and humanized neutralizing antibodies targeting SARS-CoV-2 proteins including nucleoprotein and spike protein variants, sold in multiple conjugate formats and sizes for research use.
  • SARS-CoV-2 Protein Catalog Catalog of recombinant SARS-CoV-2 proteins including spike trimers from wild-type and variant strains (Omicron, Delta, Alpha, Beta) with various tags for research applications.
  • Phospho-Specific Antibody Catalog Catalog of phospho-specific rabbit monoclonal antibodies for detection of phosphorylated proteins in applications including flow cytometry, Western blot, ELISA, and IHC, sold in unconjugated and conjugate formats.
  • Cell Surface Antibody Catalog Catalog of antibodies targeting cell surface antigens including GPCRs such as CB1 and CB2, ion channels such as Kv1.3, and other membrane proteins for flow cytometry applications, sold in multiple conjugate formats.
  • Other Research Antibodies Catalog Miscellaneous research antibodies including cleaved PARP, CTX-M, NOD1, p53, and isotype control antibodies for general research use.
  • Platform and Product Licensing / OEM Licensing of proprietary platforms (including Rabwiz, STEM, and WizAmp) and OEM supply of Abwiz products to other companies for resale or integration into their product lines.

Quantifiable outcome

  • 1,300× affinity improvement achieved (example: 5 nM KD starting affinity improved to 4 pM KD)
  • +5 more outcomes

Companies that use Abwiz Bio

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Abwiz Bio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Abwiz Bio partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Academic Research InstitutionscoreStrategic or Co-development PartnerAbwiz Bio welcomes collaboration with academic researchers for novel therapeutic mAb development or immunology studies. Company can jointly apply for NIH SBIR and STTR grants with academic partners. Open to developing antibodies in collaboration after evaluating target potential.
  • ScienceExchangeminorChannel Partner/ Reseller/ DistributorAbwiz Bio services available through ScienceExchange platform, which provides verified vendor access for research services. Platform enables academic and commercial customers to order Abwiz services through established procurement channels.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Abwiz Bio competitors and assessment

Company assessment

Direct peers

  • AbCellera Biologics: AbCellera is a leading antibody discovery CRO that uses proprietary single-cell and display technologies to deliver therapeutic antibody leads to pharma partners. It directly competes with Abwiz in custom antibody discovery for biopharma customers, though at much greater scale and capital base.
  • Adimab: Adimab operates a yeast-based antibody discovery platform serving pharma and biotech with fully human leads. It is a direct competitor in the antibody discovery CRO market, offering an alternative display technology approach to Abwiz's rabbit/phage-display platform.
  • GenScript ProBio: GenScript's ProBio division offers end-to-end antibody discovery, engineering, and manufacturing services including phage display and humanization. It overlaps directly with Abwiz's Rabwiz discovery, humanization, and affinity maturation services, but at significantly larger scale and global reach.
  • Creative Biolabs: Creative Biolabs is a CRO offering custom antibody services across hybridoma, phage display, and humanization workflows for therapeutic and diagnostic clients. It is a direct peer in the custom rabbit and humanized antibody development space with a similar fee-for-service model.
  • Absolute Antibody: Absolute Antibody offers antibody engineering, humanization, and recombinant antibody services, including reformatted rabbit monoclonals. It overlaps with Abwiz's humanization service and recombinant IgG production, and competes for therapeutic developers seeking royalty-free antibody ownership.
  • ProMab Biotechnologies: ProMab is a custom monoclonal antibody development CRO offering hybridoma, phage display, and humanization services to academic and biotech customers. It is a direct peer for custom rabbit and humanized mAb services, particularly for research-scale and preclinical projects.

Broad incumbents

  • Cell Signaling Technology: Cell Signaling Technology is a leading producer of validated antibodies and reagents for signal transduction and disease research. Its broad catalog of highly validated antibodies overlaps with Abwiz's phospho-specific and cell-surface product lines, though CST focuses on rabbit monoclonal reagents rather than custom discovery services.
  • BioLegend (PerkinElmer): BioLegend, now part of Revvity/PerkinElmer, is one of the largest catalog antibody reagent suppliers and was the prior employer of Abwiz CEO CJ Okumura. Its catalog overlaps with Abwiz's reagent business, but BioLegend is far broader and does not focus on custom rabbit mAb discovery.
  • Distributed Bio (Charles River Laboratories): Distributed Bio, now part of Charles River Laboratories, offers antibody discovery and optimization using computational and library-based methods. Its Therapeutic Antibody Discovery and AbClonal services overlap with Abwiz's Rabwiz and STEM platforms within a much larger discovery services portfolio.

Emerging players

  • Synaptic Systems: Synaptic Systems produces high-quality rabbit monoclonal antibodies for neuroscience and cell biology research. While more focused on a single research vertical, it competes with Abwiz's catalog rabbit mAb offerings for share of academic and biotech reagent budgets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Abwiz Bio social profiles

Digital presence

Abwiz Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Abwiz Bio leadership team

Management profile

Number of profiles

Profiles6 records

Abwiz Bio funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Abwiz Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abwiz Bio

What does Abwiz Bio do?

Abwiz Bio provides end-to-end custom monoclonal antibody development services using proprietary phage display technology combined with rabbit immunization. The company delivers high-affinity, high-specificity rabbit monoclonal antibodies for difficult targets including GPCRs, ion channels, and small molecules, along with antibody humanization, affinity maturation, and cell-based panning services. They also sell a catalog of 440+ research antibodies and license their proprietary platforms and products to customers globally.

Is Abwiz Bio a public or private company?

Abwiz Bio is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Abwiz Bio founded?

Abwiz Bio was founded in 2012. It employs 1 to 10 people.

Where is Abwiz Bio based?

Abwiz Bio is headquartered in San Diego, United States, in the North America region.

How does Abwiz Bio make money?

Three revenue lines are on record. Custom Antibody Development Services are the primary driver. The others are catalog Antibody Products and licensing and OEM.

Who are Abwiz Bio's main competitors?

Direct peers on record are AbCellera Biologics, Adimab, GenScript ProBio, Creative Biolabs, Absolute Antibody and ProMab Biotechnologies. Broad incumbents are Cell Signaling Technology, BioLegend (PerkinElmer) and Distributed Bio (Charles River Laboratories). Synaptic Systems is listed as an emerging player.

Does Abwiz Bio have an API?

No public API is recorded for Abwiz Bio.

What industry is Abwiz Bio in?

Abwiz Bio's product category is Custom Antibody Development Services. Its primary akta.pro industry code is HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales